Prediction: This Will Be SpaceX's Stock Price by the End of 2026

The article warns SpaceX’s valuation implies aggressive outcomes, arguing that risk appetite is deteriorating ahead of the November midterms and skepticism over AI spending could weigh on the stock. It cites 2026 revenue estimates of about $37B and shows that even a 50x sales scenario would imply ~14.5% downside to roughly $140 (below the $150 opening price on June 12). Net: bearish outlook with potential near-term sentiment pressure rather than a fundamental earnings update.

Analysis

This is less a company-specific catalyst than a vote on whether the market still pays venture multiples for capital-intensive, pre-earnings platform stories. In the near term, SPCX is most exposed to a multiple reset: when risk appetite fades, the price can weaken faster than any fundamental estimate changes because the buyer base is momentum- and narrative-driven, not cash-flow-driven. That makes the first-order trade a sentiment one, but the second-order risk is forced de-rating across adjacent “future platform” names that need continued external funding.

The key mechanism is financing optionality. If the market concludes that one cash-generating business line cannot subsidize the rest of the ambition stack, then any incremental spending on AI compute or space expansion becomes dilutive rather than strategic, and the discount rate rises for the whole ecosystem. Over 1-3 months, watch for any need to raise capital, any hesitation on capex, or evidence that monetization is lagging the spend curve; those are the data that would turn a valuation debate into a balance-sheet debate.

Contrarianly, the bearish view may be underpricing scarcity. If the underlying platform keeps compounding and management proves it can self-fund growth, the stock can re-rate back toward premium growth multiples despite the lack of current earnings. The thesis is falsified by sustained upside revisions to revenue and gross margin, or by clear evidence that new initiatives are being funded without meaningful dilution; absent that, the burden of proof stays on the bulls.

Key Decisions for Investors

• Avoid chasing SPCX strength; if the name re-tests post-IPO support and fails on heavy volume, consider a 3-6 month put spread to express valuation compression with defined risk.
• Use SPCX as a hedge against speculative growth exposure: pair a small short SPCX against a long basket of cash-generative AI leaders (e.g., NVDA/MSFT) if you want to isolate the quality-vs-story spread over the next 1-3 months.
• Set a financing alert: if management flags any need for external capital, or if capex guidance rises without a corresponding monetization step-up, add to the short or hedge immediately; that is the clearest falsifier for the bull case.
• If you want broader exposure to the same theme, prefer a short on the weakest public space/AI-beta proxy rather than SPCX alone; the trade is stronger if sympathy weakness shows up in RKLB/ASTS/LUNR on no company-specific news.